Searchable abstracts of presentations at key conferences in endocrinology

ea0021p363 | Steroids | SFEBES2009

Is increased 11β-HSD1 expression a key factor underpinning intrinsic and extrinsic skin aging?

Tiganescu Ana , Mayes Andrew , Hardy Rowan , Stewart Paul , Walker Elizabeth

Glucocorticoids are highly detrimental to skin integrity and function both when used locally for anti-inflammatory treatments and during conditions of raised systemic concentrations such as Cushing’s syndrome. Many of the adverse effects of glucocorticoids on skin are also symptoms associated with natural intrinsic aging and extrinsic photoaging.Locally, glucocorticoid availability is regulated independently of circulating levels by 11β-hydroxy...

ea0020p257 | Bone/Calcium | ECE2009

Primary hyperparathyroidism surgery: team report 2002–2008

Allen Miguel , Rafael Ana , Xio Carlos , Fernandes Luis , Torrinha Joaquim

Introduction: Single adenoma is the most frequent cause of Primary hyperparathyroidism (HPT1). Surgical excision has a high success rate, particularly when associated with a fast intraoperative intact parathyroid hormone assay (PTHi).Aim: Evaluate the success rate of primary hyperparathyroidism surgery in our unit.Methods: Descriptive study of the last 33 consecutive HPT1 patients who undertook surgery, 27 of which with PTHi. The P...

ea0016p96 | Bone and calcium | ECE2008

Effects on bone turnover and bone mineral density of levothyroxine suppressive therapy in patients with benign nodular goiter

Duarte Leone , Silva-Nunes Jose , Lopes Ana-Filipa , Malheiro Fernando

Introduction: Thyroid hormones play an important role in bone metabolism. The potential action of prolonged levothyroxine therapy on bone mass reduction is still a matter of debate.Objective: The aim of the present study was to assess the effects of levothyroxine treatment on bone mineral density (BMD) and biochemical bone turnover markers.Methods: We determined thyroid function – TSH and free T4 (FT4), r...

ea0015p390 | Thyroid | SFEBES2008

Expression and subcellular localisation of VEGFRs in human thyroid follicular cells

Susarla Radhika , Gonzalez Ana-Maria , Watkinson John , Eggo Margaret

Using qRT-PCR, we found that normal human thyroid follicular cells in culture express the mRNAs for the receptors for vascular endothelial growth factors (VEGFRs). qRT-PCR revealed that the relative production of mRNAs for VEGFRs was neuropilin1=neuropilin2=VEGFR2>VEGFR1 >VEGFR3. Western blotting for phosphoVEGFR2 showed labelling of a 235 kDa protein with few degradation products. VEGFR2 is likely in its active, phosphorylated form, because thyroid cells secrete large...

ea0013oc1 | Steroid synthesis and action | SFEBES2007

Monogenic polycystic ovary syndrome (PCOS) due to novel mutations in the H6PD gene - apparent cortisone reductase deficiency (ACRD)

Slabbert Ana , Lavery Gareth , Connell John , Walker Elizabeth , Stewart Paul

ACRD presents with clinical features of hyperandrogenism in females similar to those of PCOS (acne, hirsutism, oligomenorrhea, infertility), and precocious puberty in males. Obesity also occurs in some cases. Increased cortisol clearance leads to an increased hypothalamic-pituitary-adrenal axis drive resulting in elevated serum androgen levels and a decreased urinary cortisol metabolite: cortisone metabolite ratio below 0.5 (normal adult range 0.7–1.3). These observations...

ea0056p259 | Calcium & Vitamin D metabolism | ECE2018

Primary hyperparathyroidism: a rare cause of hypertension?

Lopes Ana , Palma Isabel , Teixeira Sofia , Cardoso Helena

Backgroud: Primary hyperparathyroidism is the most common cause of hypercalcemia, which is associated with an increased frequency of hypertension. However, there are no data on the prevalence of primary hyperparathyroidism in patients who present with hypertension.Clinical case: We present the case of a 40-year-old woman with a history of hypertension for ten years. In 2017 she was referred for evaluation of hypercalcemia. The patient denied any symptoms...

ea0056p810 | Pituitary - Clinical | ECE2018

Male hypogonadism – when two endocrine causes merge in the same patient

Araujo Alexandra Novais , Wessling Ana , Bugalho Maria Joao

Introduction: Male hypogonadism is defined by lower levels of testosterone than expected for age-matched individuals. In primary or hypergonadotropic hypogonadism, LH and FSH show a compensatory elevation to low testosterone levels, while in the secondary or hypogonadotropic hypogonadism the low testosterone levels are a result of insufficient gonadotropin levels. Hyperprolactinemia is a cause of hypogonadotropic hypogonadism. It is not only caused by lactotroph adenomas (prol...

ea0056ep27 | Adrenal and Neuroendocrine Tumours | ECE2018

Optic neuritis and ectopic Cushing Syndrome: a case report

Matos Tania , Costa Cristiana , Martins Ana Filipa , Vale Sonia

Introduction: Ectopic Cushing syndrome caused by a neuroendocrine tumor is uncommon and it’s diagnosis is often delayed. Optic neuritis is another rare disease, with some cases also associated to neuroendocrine tumors.Case-report: A 43-year-old female was referred to the endocrinology outpatient’s department due to obesity. She had a past history of bilateral optic neuritis of unknown etiology. She complained of weight gain, hair loss, acne, hi...

ea0073aep169 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Glycemic control and complication rate through pregnancy and thirteen-years post-partum in women with microalbuminuria (type 1 diabetes T1DM)

Asatiani Natalia , Kurashvili Ramaz , Inashvili Ekaterine , Shelestova Elena , Kopaleishvili Ana

The aim of the present work was to assess the degree of glycemic control and complications rate through pregnancy and thirteen-years post-partum in women with microalbuminuria (T1DM).Materials and methodsIn total 191 patients with T1DM were enrolled in the study. Based on albuminuria levels in the 1st trimester women were separated into 2 groups (Gr.). Gr.1 – 116 women with normoalbuminuria, Gr.2 – 75 women wit...

ea0073aep665 | Thyroid | ECE2021

Could ultrasound characteristics guide us on the presence of malignancy in thyroid nodules with Bethesda III cytology?

Suset Dueñas Disotuar , Ana R. Romero LLuch , Navarro Elena

BackgroundThyroid nodules with indeterminate cytology represent a therapeutic challenge. The probability of malignancy had been established between 5 and 15%, but it varies among the published data. Nowadays we have molecular tests to help in therapeutic decisions, but they are not available at all centers leaving uncertainty regarding appropriate management.Objectives– To know the percentage of malignan...